Ukko
On a mission to solve food allergies and sensitivities
United States · $85.0M raised
- Employees
- 11–50
- Business Model
- B2B
- Website
- ukko.us
- Total Funding
- $85.0M
- Last Round
- $45.0M Series CJan 2026
- Rounds
- 2
About
Biotechnology company designing immunotherapies for food allergies and sensitivities using machine learning and protein engineering.
Summary
Ukko is a Biotech company based in United States. It has raised $85.0M in total across 2 rounds, most recently a $45.0M Series C round in Jan 2026. Investors include Leaps by Bayer, Israel Biotech Fund and Khosla Ventures.
Tech & App Stack
2 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jan 2026
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ukko"><img src="https://indexed.vc/api/badge/company/ukko" alt="Ukko on Indexed.vc" width="260" height="76" /></a>